Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Sale
The global fibromyalgia treatment market size attained a value of USD 2612.68 million in 2022. The market is further expected to grow at a CAGR of 8.10% between 2023 and 2028, to reach a value of USD 4169.08 million by 2028.
Fibromyalgia is defined as a musculoskeletal disorder which causes intense pain, fatigue, sleep, mood swings, headache, depression, and memory issues. This disorder increases the pain sensations to the brain and spinal cord. As there is no definitive cure, fibromyalgia treatment is aimed at providing comfort to the patients using medications and specialised drugs. Women are more susceptible to fibromyalgia.
Based on drug class, the market is segmented into antidepressants, antiepileptic, muscle relaxants, and analgesics, among others. On the basis of distribution channel, the market is classified into hospital pharmacy, retail pharmacy, and online pharmacy, among others. The regional markets for fibromyalgia treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global fibromyalgia treatment market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
The antidepressant segment, based on drug class, accounts for a sizable fibromyalgia treatment market share. Antidepressants are an effective medication which reduces severe depression and feelings of trauma or exhaustion, while preventing their resurgence. Antidepressants are recommended by many doctors or pharmacists as they are safe and well-researched. In addition, these medicines can improve the quality of life by providing energy to carry out various day to day activities, which is expected to contribute to the fibromyalgia treatment market price. Meanwhile, the muscle relaxants segment is expected to witness a steady growth in the forecast period as it helps patients cope with muscle stress and tension.
As per the fibromyalgia treatment market report, the retail pharmacy segment accounts for a significant share of the market, based on distribution channel. This can be attributed to wider network and easier accessibility of retail pharmacies. Further, retail pharmacies bring greater convenience to people as it is usually available across remote and major locations in both urban and rural areas. Meanwhile, the online pharmacy segment is expected to register a decent growth in the forecast period due to the rising purchasing power and rapid digitalisation in the pharmaceutical and healthcare sector across the emerging economies.
Pfizer, Inc. is a leading pharmaceutical and biotechnology company which produces high-quality medications for the treatment of chronic conditions. It also carries out clinical trials and vaccine development to combat lethal infections. The company was established in the year 1849 and is currently headquartered in New York, United States.
Eli Lilly and Company is a major pharmaceutical company which is headquartered in Indiana in the United States. The company was established in the year 1876 and currently manufactures high-quality medicines. Segments of this company include diabetes solution centre, oncology support centre, and insulin state patient assistance programmes, among others.
Novartis AG is a prominent pharmaceutical corporation which was founded in 1996 and is currently headquartered in Basel, Switzerland. The company caters to the medical demands of patients suffering from oncological, ophthalmology, and neuro conditions, among others. Novartis AG innovates in digital and scientific technologies to transform the treatment infrastructure in order to improve patient health.
Other market players include Allergan plc, Sun Pharmaceutical Industries Ltd, Intec Pharma Ltd, Astellas Pharma Inc, and Prismic Pharmaceuticals, Inc., among others.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Drug Class |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Fibromyalgia Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Fibromyalgia Treatment Historical Market (2018-2022)
8.3 Global Fibromyalgia Treatment Market Forecast (2023-2028)
8.4 Global Fibromyalgia Treatment Market by Drug Class
8.4.1 Antidepressants
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Antiepileptic
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Muscle Relaxants
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Analgesics
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Others
8.5 Global Fibromyalgia Treatment Market by Distribution Channel
8.5.1 Hospital Pharmacy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Retail Pharmacy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Online Pharmacy
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Fibromyalgia Treatment Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
9 North America Fibromyalgia Treatment Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Fibromyalgia Treatment Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Fibromyalgia Treatment Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Fibromyalgia Treatment Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Fibromyalgia Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Pfizer, Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Eli Lilly and Company
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Novartis AG
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Allergan plc
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Sun Pharmaceutical Industries Ltd
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Intec Pharma Ltd
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Astellas Pharma Inc
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Prismic Pharmaceuticals, Inc.
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Fibromyalgia Treatment Market: Key Industry Highlights, 2018 and 2022
2. Global Fibromyalgia Treatment Historical Market: Breakup by Drug Class (USD Million), 2018-2022
3. Global Fibromyalgia Treatment Market Forecast: Breakup by Drug Class (USD Million), 2023-2028
4. Global Fibromyalgia Treatment Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
5. Global Fibromyalgia Treatment Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
6. Global Fibromyalgia Treatment Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Fibromyalgia Treatment Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Fibromyalgia Treatment Market Structure
The market reached a value of USD 2612.68 million in 2022.
The market is estimated to grow at a CAGR of 8.10% in the forecast period of 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach a value of USD 4169.08 million by 2028.
The increasing prevalence of fibromyalgia, increasing women population, rising health awareness, and increasing diagnosis infrastructure across the emerging economies are the major drivers of the market.
The key trends in the market include the emerging online retail pharmacies, rising standards of living, and favourable policies of the government.
Antidepressants, antiepileptic, muscle relaxants, and analgesics, among others, are the different drug classes included in the market report.
Hospital pharmacy, retail pharmacy, and online pharmacy, among others, are the segments of the market based on distribution channels.
Family genetics, poor lifestyle, improper nutrition, certain infections, and incidences of physical and emotional trauma can lead to fibromyalgia.
Although, a complete cure for fibromyalgia is not yet available, medications and therapeutics can help reduce the symptoms of this condition.
Pfizer, Inc., Eli Lilly and Company, Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd, Intec Pharma Ltd, Astellas Pharma Inc, and Prismic Pharmaceuticals, Inc., among others, are the key market players, according to the fibromyalgia treatment market report.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.